Progression of Late-Onset Stargardt Disease

Progression of Late-Onset Stargardt Disease

Purpose: Identification of sensitive biomarkers is essential to determine potential effects of emerging therapeutic trials for Stargardt disease. This study aimed to describe the natural history of late-onset Stargardt, and demonstrates the accuracy of retinal pigment epithelium (RPE) atrophy progre...

Full description

Bibliographic Details
Main Authors:	Lambertus, S, Lindner, M, Bax, N, Mauschitz, M, Nadal, J, Schmid, M, Schmitz-Valckenberg, S, Hollander, A, Weber, B, Holz, F, van der Wilt, G, Fleckenstein, M, Hoyng, C, Foveal sparing Atrophy Study Team (FAST)
Format:	Journal article
Language:	English
Published:	Association for Research in Vision and Ophthalmology 2016

Similar Items

Differential disease progression in atrophic age-related macular degeneration and late-onset stargardt disease
by: Lindner, M, et al.
Published: (2017)

Choroidal Flow Signal in Late-Onset Stargardt Disease and Age-Related Macular Degeneration: An OCT-Angiography Study
by: Müller, PL, et al.
Published: (2018)

Combined Fundus Autofluorescence and Near Infrared Reflectance as Prognostic Biomarkers for Visual Acuity in Foveal-Sparing Geographic Atrophy
by: Lindner, M, et al.
Published: (2017)

Green-light autofluorescence versus combined blue-light autofluorescence and near-infrared reflectance imaging in geographic atrophy secondary to age-related macular degeneration
by: Pfau, M, et al.
Published: (2017)

Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease.
by: Stanley Lambertus, et al.
Published: (2017-01-01)

The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients [version 3; peer review: 2 approved]
by: Philipp T. Möller, et al.
Published: (2022-09-01)

Local progression kinetics of geographic atrophy in age-related macular degeneration are associated with atrophy border morphology
by: Lindner, M, et al.
Published: (2018)

Late-onset Stargardt disease
by: Joseph B. Alsberge, et al.
Published: (2022-06-01)

Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation
by: Charlotte Behning, et al.
Published: (2021-08-01)

Systemic complement activation levels in Stargardt disease.
by: Patty P A Dhooge, et al.
Published: (2021-01-01)

Structural changes in optical coherence tomography underlying spots of increased autofluorescence in the perilesional zone of geographic atrophy
by: Oishi, M, et al.
Published: (2017)

Determinants of reading performance in eyes with foveal-sparing geographic atrophy
by: Lindner, M, et al.
Published: (2018)

Light sensitivity within areas of geographic atrophy secondary to age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Prognostic value of shape-descriptive factors for the progression of geographic atrophy secondary to age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases
by: Pfau, M, et al.
Published: (2017)

Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
by: von der Emde, L, et al.
Published: (2019)

Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen
by: Pfau, M, et al.
Published: (2018)

OCT angiography-based detection and quantification of the neovascular network in exudative AMD
by: Lindner, M, et al.
Published: (2016)

Commentary on “Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes”
by: Patty P.A. Dhooge, et al.
Published: (2021-09-01)

Test-retest reliability of scotopic and mesopic fundus-controlled perimetry using a modified MAIA (macular integrity assessment) in normal eyes
by: Pfau, M, et al.
Published: (2016)

DHA supplementation for late onset Stargardt disease: NAT-3 study
by: Giuseppe Querques, et al.
Published: (2010-06-01)

Mesopic and dark-adapted two-color fundus-controlled perimetry in geographic atrophy secondary to age-related macular degeneration
by: Pfau, M, et al.
Published: (2018)

Determinants of cone- and rod-function in geographic atrophy: AI-based structure-function correlation
by: Pfau, M, et al.
Published: (2020)

Monitoring and Management of the Patient with Stargardt Disease
by: Cicinelli MV, et al.
Published: (2019-11-01)

Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A
by: Nuria Suárez-Herrera, et al.
Published: (2023-12-01)

La dystrophie maculaire de Stargardt
by: M. Boutkhil, et al.
Published: (2017-05-01)

Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare <i>ABCA4</i> Variant in a Child with Early-Onset Stargardt Disease
by: Nuria Suárez-Herrera, et al.
Published: (2024-03-01)

Inferred retinal sensitivity in recessive Stargardt disease using machine learning
by: Philipp L. Müller, et al.
Published: (2021-01-01)

Therapy Approaches for Stargardt Disease
by: Elena Piotter, et al.
Published: (2021-08-01)

Generation of iPSC lines from three Stargardt patients carrying bi-allelic ABCA4 variants
by: Dyah W. Karjosukarso, et al.
Published: (2023-09-01)

A Novel ABCA4 Mutation Associated with a Late-Onset Stargardt Disease Phenotype: A Hypomorphic Allele
by: Cindy S. Kaway, et al.
Published: (2017-03-01)

Children and the Holocaust: An Interview with Nicholas Stargardt
by: Ben Mercer
Published: (2000-06-01)

Effects of Photo-Biomodulation in Stargardt Disease
by: Scalinci SZ, et al.
Published: (2022-01-01)

Genetic testing for Stargardt macular dystrophy
by: Abeshi Andi, et al.
Published: (2017-10-01)

Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials
by: Pfau, M, et al.
Published: (2020)

Clinical and Genetic Spectrum of Stargardt Disease in Argentinean Patients
by: Marcela D. Mena, et al.
Published: (2021-03-01)

Multimodal in-vivo maps as a tool to characterize retinal structural biomarkers for progression in adult-onset Stargardt disease
by: Hilde R. Pedersen, et al.
Published: (2024-04-01)

Case series of Stargardt's disease: Our experience
by: Syed Abdul Wadud, et al.
Published: (2016-08-01)

Reading strategies in Stargardt's disease with foveal sparing
by: Whatham Andrew R, et al.
Published: (2010-01-01)